Your browser doesn't support javascript.
loading
Major improvements in health-related quality of life during the use of etanercept in patients with previously refractory juvenile idiopathic arthritis.
Prince, F H M; Geerdink, L M; Borsboom, G J J M; Twilt, M; van Rossum, M A J; Hoppenreijs, E P A H; Cate, R Ten; Koopman-Keemink, Y; van Santen-Hoeufft, M; Raat, H; van Suijlekom-Smit, L W A.
Affiliation
  • Prince FH; Department of Paediatrics/Paediatric Rheumatology, Sp 1546, Erasmus MC Sophia Children's Hospital, PO Box 2060, 3000 CB Rotterdam, The Netherlands. f.prince@erasmusmc.nl
Ann Rheum Dis ; 69(1): 138-42, 2010 Jan.
Article in En | MEDLINE | ID: mdl-19581280

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Juvenile / Quality of Life / Immunoglobulin G / Health Status / Receptors, Tumor Necrosis Factor / Antirheumatic Agents Type of study: Clinical_trials / Observational_studies / Prognostic_studies Aspects: Determinantes_sociais_saude / Patient_preference Limits: Adolescent / Child / Female / Humans / Male Language: En Journal: Ann Rheum Dis Year: 2010 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Juvenile / Quality of Life / Immunoglobulin G / Health Status / Receptors, Tumor Necrosis Factor / Antirheumatic Agents Type of study: Clinical_trials / Observational_studies / Prognostic_studies Aspects: Determinantes_sociais_saude / Patient_preference Limits: Adolescent / Child / Female / Humans / Male Language: En Journal: Ann Rheum Dis Year: 2010 Document type: Article